• Home
  • NEW DAY MEDICINE
  • 9 (83) 2025
  • 6 -9 (83) 2025 - Juraeva D.N. - MODERN ASPECTS OF IMMUNOLOGICAL MARKERS IN THE EARLY DIAGNOSIS AND PROGNOSIS OF TRIGEMINAL NEURALGIA

6 -9 (83) 2025 - Juraeva D.N. - MODERN ASPECTS OF IMMUNOLOGICAL MARKERS IN THE EARLY DIAGNOSIS AND PROGNOSIS OF TRIGEMINAL NEURALGIA

MODERN ASPECTS OF IMMUNOLOGICAL MARKERS IN THE EARLY DIAGNOSIS AND PROGNOSIS OF TRIGEMINAL NEURALGIA

Juraeva D.N. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

We visited Bukhara region, Jondor District Medical Association, Central Polyclinic, where 92 patients with trigeminal neuralgia aged 17 to 70 years and 30 patients in the control group were prescribed interleukin -17 (IL-17) in blood serum. 53 of the patients involved in the study were 1 group of patients with very strong pain intensity and 39 patients with moderate intensity pain

Keyword: trigeminal neuralgia, pain syndrome, interleukin -17 (IL-17)

First page

26

Last page

29

For citation:Juraeva D.N. - MODERN ASPECTS OF IMMUNOLOGICAL MARKERS IN THE EARLY DIAGNOSIS AND PROGNOSIS OF TRIGEMINAL NEURALGIA//New Day in Medicine 9(83)2025 26-29 https://newdayworldmedicine.com/en/new_day_medicine/9-83-2025

List of References

  1. Джон Брильман, Скотт Коэн. Неврология. — МЕД пресс-информ, 2007; 226. — (In a Page). — 2000 экз. — ISBN 5-98322-264-3.
  2. Манвелов Л. С., Тюрников В. М., Кадыков А. В. Тригеминальная невралгия: эпидемиология, этиология, патоморфология, патогенез, клиника, диагностика // Русский медицинский журнал. 2013;21(10):542-544. — ISSN 2225-2282.
  3. Оберманн М. Последние достижения в понимании/лечении невралгии тройничного нерва. F1000Research. 2019;8:505. doi: 10.12688/f1000research.16092.1. [ DOI ] [ Бесплатная статья PMC ] [ PubMed ] [ Google Scholar ]
  4. Неврология. Национальное руководство. — ГЭОТАР-Медиа, 2010. — 2116 с. — 2000 экз. — ISBN 978-5-9704-0665-6.
  5. Jump up to:a b c Okeson JP (2005). "6". In Lindsay Harmon (ed.). Bell's orofacial pains: the clinical management of orofacial pain. Quintessence Publishing Co, Inc. p. 115. ISBN 0-86715-439-X. Archived from the original on 2014-01-12.
  6. Jiang X., Zhou R., Zhang Y. “Interleykin-17 as a potential therapeutic target for chronic pain”. Immunologi 29. Siptember 2022.

    file

    download